Gene · 55000
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA TUG1 promotes chondrosarcoma progression and M2 polarization. | Genes Dis | 2025 | 40330150 | PubTator, text mining | PubMed |
| Long non-coding RNAs in schizophrenia. | Clin Chim Acta | 2025 | 40311728 | PubTator, text mining | PubMed |
| LncRNA MEG3 independently collaborates with lncRNA TUG1 to prevent cholesterol efflux in ox-LDL-induced human umbilical vein endothelial cells. | Mol Biol Rep | 2025 | 40293536 | PubTator, text mining | PubMed |
| Enhancement of YTHDF2 plays a protective role in acute IRI models through downregulation of TUG1 expression. | PLoS One | 2025 | 40273066 | PubTator, text mining | PubMed |
| Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. | Cell Death Discov | 2025 | 40258841 | PubTator, text mining | PubMed |
| The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases. | Int J Mol Sci | 2025 | 40243658 | PubTator, text mining | PubMed |
| RETRACTION: LncRNA TUG1 Relieves Renal Mesangial Cell Injury by Modulating the miR-153-3p/Bcl-2 Axis in Lupus Nephritis. | Immun Inflamm Dis | 2025 | 40214152 | PubTator, text mining | PubMed |
| Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer. | Med Oncol | 2025 | 39992529 | PubTator, text mining | PubMed |
| Innovative perspectives on glioblastoma: the emerging role of long non-coding RNAs. | Funct Integr Genomics | 2025 | 39992471 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of the impact of abnormal expression of long non coding RNA on the prognosis of acute myeloid leukemia. | Front Genet | 2025 | 39967688 | PubTator, text mining | PubMed |
| Retraction Note: Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1/miR-200c-3p/SIRT1 axis. | J Inflamm (Lond) | 2025 | 39966817 | PubTator, text mining | PubMed |
| Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma. | BMC Cancer | 2025 | 39948537 | PubTator, text mining | PubMed |
| Predictive Value of LncRNA TUG1 for Complications after Caesarean Section with Scarred Uterus. | Tohoku J Exp Med | 2025 | 39938913 | PubTator, text mining | PubMed |
| Progress on long non-coding RNAs in calcific aortic valve disease. | Front Cardiovasc Med | 2025 | 39898106 | PubTator, text mining | PubMed |
| LncRNA TUG1 Repressed Angiogenesis by Promoting the Ubiquitination of HuR and Inhibiting Its Nuclear Translocation in Cerebral Ischemic Reperfusion Injury. | Adv Sci (Weinh) | 2025 | 39887590 | PubTator, text mining | PubMed |
| Identification of IGF2BP2 and long non-coding RNA TUG1 for the prognosis and tumour microenvironment in head and neck squamous cell carcinoma. | Acta Otorhinolaryngol Ital | 2025 | 39844758 | PubTator, text mining | PubMed |
| ALKBH5 knockdown suppresses gastric cancer progression by reducing the expression of long non-coding RNA TUG1. | Toxicol Res (Camb) | 2025 | 39830887 | PubTator, text mining | PubMed |
| LncRNA TUG1 mitigates chronic kidney disease through miR-542-3p/HIF-1α/VEGF axis. | Heliyon | 2025 | 39811365 | PubTator, text mining | PubMed |
| Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics. | Biochem Genet | 2025 | 39636332 | PubTator, text mining | PubMed |
| YAP1 overexpression aggravates the progress of diabetic retinopathy by activating the TUG1/miR-144-3p/VEGFA signaling pathway in the hypoxia-induced DR MRMECs model. | Tissue Cell | 2025 | 39615227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55000/papers?page=6